natgillin/translations-raw huggingface dataset:
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni „brez natrija“.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.
Zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar dejansko pomeni, da je “brez natrija”.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially “sodium-free”.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar bistvu pomeni „brez natrija“.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially “sodium-free”.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni „brez natrija“.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially “sodium-free”.
Zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek; kar v bistvu pomeni "brez natrija".
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially “sodium-free”.
Zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni “brez natrija”.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially “sodium-free”.
Zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, t.j. pravzaprav “brez natrija”.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. it is essentially ‘sodium free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. it is essentially ‘sodium- free’ and should not affect a sodium-controlled diet.
Zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek; to pomeni, da je praktično "brez natrija" in ne bi smelo vplivati na prehrano z nadzorovano količino natrija.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. it is essentially ‘sodium- free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar pomeni, da je praktično "brez natrija".
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e., essentially ‘sodium- free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per maximum dose, i.e. essentially ‘sodium free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na največji odmerek, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per ml, i.e. essentially ‘sodium- free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na ml, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per ml, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni ‛brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per pre-filled syringe, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na napolnjeno injekcijsko brizgo, kar v bistvu pomeni 'brez natrija'.
This medicine contains less than 1 mmol sodium (23 mg) per pre-filled syringe, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na napolnjeno injekcijsko brizgo, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per pre-filled syringe, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na napolnjeno brizgo, kar v bistvu pomeni 'brez natrija'.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially sodium-free.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na vialo, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially ‘sodium free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na vialo, kar v bistvu pomeni „brez natrija“.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially ‘sodium- free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) v eni viali, kar v bistvu pomeni “brez natrija”.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially ‘sodium- free’.
Zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na vialo, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially ‘sodium-free’.
Ena viala zdravila vsebuje manj kot 1 mmol natrija (23 mg) kar praktično pomeni, da “ne vsebuje natrija”.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na vialo, kar pomeni, da je v bistvu »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially ‘sodium-free’.
Zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na vialo, kar pomeni, da je praktično "brez natrija".
This medicine contains less than 1 mmol sodium (23 mg) per vial, which means it is essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na vialo, kar v bistvu pomeni "brez natrija".
This medicine contains less than 1 mmol sodium (23 mg) per vial.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na vialo.
This medicine contains less than 1 mmol sodium (23 mg), which means it is essentially “sodiumfree”.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija, kar v bistvu pomeni "brez natrija".
This medicine contains less than 1 mmol sodium per dose, i.e. it is essentially ´sodium free´.
Zdravilo vsebuje manj kot 1 mmol natrija na odmerek, kar v bistvu pomeni, da je „brez natrija“.
This medicine contains less than 23 mg of sodium per vial, which means that it is essentially “sodium free”.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni "brez natrija".
This medicine contains less than 23 mg of sodium per vial, which means that it is essentially “sodium- free”.
Zdravilo Angiox vsebuje manj kot 23 mg natrija na vialo, to dejansko pomeni, da je »brez natrija«.
This medicine contains less than 23 mg of sodium, which means it is essentially “sodium-free”.
To zdravilo vsebuje manj kot 23 mg natrija, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 23 mg sodium per 17 ml vial, i.e., it is essentially “sodium free”.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 1 vialo (17 ml), kar v bistvu pomeni “brez natrija”.
This medicine contains lSepiogline monohydrate.
To zdravilo vsebuje laktozo monohidrat.
This medicine contains mannitol and aspartame (E951).
To zdravilo vsebuje manitol in aspartam (E951).
This medicine contains metacresol which may cause allergic reactions.
Zdravilo vsebuje metakrezol, ki lahko povzroči alergijske reakcije.
This medicine contains phenylalanine and may be harmful for people with phenylketonuria (genetic enzyme deficiency that increases excretion of a chemical (phenylketone) in urine and may cause nervous system disorders).
To zdravilo vsebuje fenilalanin, ki lahko škoduje ljudem s fenilketonurijo (genetsko pomanjkanje encima, ki zvišuje izločanje kemikalije (fenilketona) v seč in ki lahko povzroči bolezni živčnega sistema).
This medicine contains phenylalanine.
To zdravilo vsebuje fenilalanin.
This medicine contains potassium, less than 1 mmol (39 mg) per administration at 27 injection sites to 60 injection sites, i.e. essentially ‘potassium-free’.
To zdravilo vsebuje manj kot 1 mmol (39 mg) kalija na uporabo na 27 do 60 mestih injiciranja, tj. je skoraj „brez kalija“.
This medicine contains potassium, less than 1 mmol (39 mg) per vial, and can therefore be considered as essentially “potassium-free”.
To zdravilo vsebuje manj kot 1 mmol (39 mg) kalija na vialo, kar v bistvu pomeni „brez kalija“.
This medicine contains potassium, less than 1 mmol (39 mg) per vial, i.e. essentially “potassium-free”.
To zdravilo vsebuje manj kot 1 mmol (39 mg) kalija na vialo, kar v bistvu pomeni „brez kalija“.
This medicine contains potassium, less than 1mmol/dose and sodium, less than 1mmol/dose.
To zdravilo vsebuje manj kot 1 mmol kalija na odmerek in manj kot 1 mmol natrija na odmerek.
This medicine contains small amounts of ethanol (alcohol), less than 100 mg in a vial.
Zdravilo vsebuje majhne količine etanola (alkohola), manj kot 100 mg na vialo.
This medicine contains sodium chloride.
To zdravilo vsebuje natrijev klorid.
This medicine contains sorbitol (a type of sugar).
To zdravilo vsebuje sorbitol (vrsta sladkorja).
This medicine contains sorbitol (a type of sugar).
To zdravilo vsebuje sorbitol (vrsto sladkorja).
This medicine contains sucrose and sorbitol (types of sugar).
To zdravilo vsebuje saharozo in sorbitol (vrsti sladkorja).
This medicine contains sucrose, sorbitol and may contain soya - see section 2 for more information.
To zdravilo vsebuje saharozo in sorbitol ter lahko vsebuje sojo - za več informacij glejte poglavje 2.
This medicine contains sucrose, which is a type of sugar.
Zdravilo vsebuje vrsto sladkorja, saharozo.
This medicine contains the active substance busulfan, which belongs to a group of medicines called alkylating agents.
To zdravilo vsebuje aktivno učinkovino busulfan, ki spada v skupino zdravil, imenovanih alkilirajoče učinkovine.
This medicine contains the active substance follitropin alfa, which is almost identical to a natural hormone produced by your body called “follicle-stimulating hormone” (FSH).
To zdravilo vsebuje zdravilno učinkovino folitropin alfa, ki je skoraj enaka naravnemu hormonu, imenovanemu „folikle stimulirajoči hormon (FSH)“, ki ga tvori vaše telo.
This medicine contains the active substance follitropin alfa, which is almost identical to a natural hormone produced by your body called “follicle-stimulating hormone” (FSH).
To zdravilo vsebuje zdravilno učinkovino folitropin alfa, ki je skoraj identična z naravnim hormonom, ki nastaja v telesu, imenovanim "folikle stimulirajoči hormon" (FSH).
This medicine contains the active substance human alpha1-proteinase inhibitor, which is a normal component of the blood and is found in the lung.
To zdravilo vsebuje zdravilno učinkovino humani zaviralec alfa1-proteinaze, ki je normalna sestavina krvi in se najde v pljučih.
This medicine contains the active substance radium Ra 223 dichloride (radium-223 dichloride).
To zdravilo vsebuje zdravilno učinkovino [223Ra]radijev klorid (radium Ra 223 dichloride).
This medicine contains thiomersal as a preservative and it is possible that you may experience an allergic reaction.
Zdravilo vsebuje tiomersal kot konzervans, zato boste morda imeli alergijske reakcije.
This medicine contains two active ingredients called aclidinium and formoterol fumarate dihydrate.
Zdravilo vsebuje dve zdravilni učinkovini, imenovani aklidinij in formoterolijev fumarat dihidrat.
This medicine contains two different substances called:
To zdravilo vsebuje dve različni zdravilni učinkovini, imenovani:
This medicine contains up to 14.75 mg (0.64 mmol) sodium per vial.
To zdravilo vsebuje do 14,75 mg (0,64 mmol) natrija na vialo.
This medicine contains up to 29.5 mg (1.28 mmol) sodium per vial.
To zdravilo vsebuje do 29,5 mg (1,28 mmol) natrija na vialo.
This medicine contains up to 29.50 mg (1.28 mmol) sodium per vial.
To zdravilo vsebuje do 29,50 mg (1,28 mmol) natrija na vialo.
This medicine contains: approximately 800 mg sodium per infusion.
približno 800 mg natrija na infuzijo.
This medicine could possibly have an effect on male fertility.
To zdravilo lahko vpliva na moško plodnost.
This medicine delivers the active substance slowly and constantly through your skin and into your blood stream for the duration that you are wearing the transdermal patch.
Ves čas uporabe transdermalnega obliža prehaja zdravilna učinkovina iz zdravila počasi in stalno skozi kožo v krvni obtok.
This medicine does not affect your ability to drive and use machines.
To zdravilo ne vpliva na sposobnost vožnje ali upravljanja s stroji.
This medicine does not effect your ability to drive or use machines.
To zdravilo ne vpliva na vašo sposobnost za vožnjo ali upravljanje s stroji.
This medicine does not require any special storage conditions
Za shranjevanje tega zdravila niso potrebna posebna navodila.
This medicine does not require any special storage conditions until the vial has been opened and the concentrate is diluted.
Za shranjevanje zdravila niso potrebna posebna navodila, dokler viala ni bila odprta in koncentrat razredčen.
This medicine does not require any special storage conditions.
Posebna navodila za shranjevanje tega zdravila niso potrebna.
This medicine does not require any special storage conditions.
Shranjujte v originalni ovojnini za zagotovitev zaščite pred vlago.
This medicine does not require any special storage conditions.
Za shranjevanje tega zdravila ni posebnih navodil.
This medicine does not require any special storage conditions.
Za shranjevanje tega zdravila ni posebnih zahtev.
This medicine does not require any special storage conditions.
Za shranjevanje zdravila ni posebnih navodil.
This medicine does not require any special storage conditions.
Za shranjevanje zdravila posebna navodila niso potrebna.
This medicine does not require any special temperature storage conditions.
Za shranjevanje tega zdravila ni posebnih navodil glede temperature.
This medicine does not require any special temperature storage conditions.
Za shranjevanje tega zdravila ni posebnih temperaturnih pogojev.
This medicine has been associated with dizziness and somnolence, which could increase the occurrence of accidental injury (fall) in elderly patients.
Zdravljenje s tem zdravilomlahko spremljata omotica in zaspanost, ki lahko pri starejših bolnikih zvečata pogostnost nezgodnih poškodb (padcev).
This medicine has been authorised under ‘exceptional circumstances’.
Zdravilo je pridobilo dovoljenje za promet v "izjemnih okoliščinah".
This medicine has been authorised under ‘exceptional circumstances’.
Zdravilo je pridobilo dovoljenje za promet v 'izjemnih okoliščinah'.
This medicine has been authorised under ‘exceptional circumstances’.
Zdravilo je pridobilo dovoljenje za promet v »izjemnih okoliščinah«.
This medicine has been authorised under ‘exceptional circumstances’.
Zdravilo je pridobilo dovoljenje za promet v “izjemnih okoliščinah”.
This medicine has been authorised under ‘exceptional circumstances’.
Zdravilo je pridobilo dovoljenje za promet v „izjemnih okoliščinah“.
This medicine has been given "conditional approval".
Zdravilo je pridobilo tako imenovano "pogojno dovoljenje za promet".
This medicine has been given ‘conditional approval’.
Zdravilo je pridobilo tako imenovano "pogojno dovoljenje za promet".
This medicine has been given ‘conditional approval’.
Zdravilo je pridobilo tako imenovano »pogojno dovoljenje za promet«.
This medicine has been given ‘conditional approval’.
Zdravilo je pridobilo tako imenovano “pogojno dovoljenje za promet”.
This medicine has been given ‘conditional approval’.
Zdravilo je pridobilo tako imenovano „pogojno dovoljenje za promet“.
This medicine has been given “conditional approval”.
Zdravilo je pridobilo tako imenovano "pogojno dovoljenje za promet".
This medicine has been given “conditional approval”.
Zdravilo je pridobilo tako imenovano ”pogojno dovoljenje za promet”.
This medicine has been given “conditional approval”.
Zdravilo je pridobilo tako imenovano „pogojno dovoljenje za promet“.
This medicine has been prescribed for you only Do not pass it on to others.
Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
This medicine has been prescribed for you only.
Zdravilo je bilo predpisano vam osebno.
This medicine has been prescribed for you personally and you should not pass it on to others.
Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
This medicine has been prescribed for you.
Zdravilo je bilo predpisano vam osebno.
This medicine has been prescribed for your child and should not be passed on to others.
To cepivo je bilo predpisano vašemu otroku in ga ne smete dajati drugim.
This medicine has been prescribed for your dog only and you should not pass it on to others.
Zdravilo je bilo predpisano samo vašemu psu in ga ne smete dajati drugim.
This medicine has minor influence on the ability to drive and use machines.
To zdravilo ima blag vpliv na sposobnost vožnje in upravljanja s stroji.
This medicine has no or negligible influence on the ability to drive and use machines.
To zdravilo nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
This medicine has no or negligible influence on the ability to drive and use machines.
To zdravilo nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
This medicine has no significant effect on your ability to drive or to operate tools or machines.
To zdravilo ne vpliva bistveno na sposobnost vožnje ali upravljanja orodij oz. strojev.
This medicine has not been studied in children and adolescents.
Pri otrocih in mladostnikih uporabe tega zdravila niso raziskovali.
This medicine has not been studied in children and adoloscents.
Zdravila Bosulif niso preučevali pri otrocih in mladostnikih.
This medicine has not been studied in children or adolescents and is therefore not to be taken by children and adolescents below the age of 18 years.
Tega zdravila niso proučevali pri otrocih ali mladostnikih, zato ga mlajši od 18 let ne smejo jemati.
This medicine has not been tested in patients with kidney or liver problems.
Tega zdravila pri bolnikih z ledvičnimi ali jetrnimi težavami niso preizkušali.
This medicine helps to improve the levels of insulin after a meal and lowers the amount of sugar made by your body.
To zdravilo izboljša raven insulina po jedi in zmanjša količino sladkorja, ki nastaja v telesu.
This medicine in combination with an alpha interferon product may also cause:
To zdravilo v kombinaciji z zdravilom z alfa interferonom lahko povzroči tudi:
This medicine in combination with an alpha interferon product may also cause:
To zdravilo v kombinaciji z zdravilom z interferonom alfa povzroči tudi:
This medicine in combination with peginterferon alfa-2b or interferon alfa-2b may also cause:
To zdravilo v kombinaciji s ali peginterferonom alfa-2b ali interferonom alfa-2b lahko povzroči tudi:
This medicine in combination with peginterferon alfa-2b or interferon alfa-2b may also cause:
To zdravilo v kombinaciji s peginterferonom alfa-2b ali interferonom alfa-2b lahko povzroči tudi:
This medicine increases the risk of having protein in your urine especially if you already have high blood pressure.
to zdravilo poveča tveganje za pojav beljakovin v seču, še posebej, če že imate visok krvni tlak;
This medicine is a pale pink powder supplied in sachets.
Zdravilo je bledo rožnat prašek in je pakirano v vrečkah.
This medicine is also used to treat an inherited disease called BH4 deficiency in adults and children of all ages, in which the body cannot produce enough BH4.
To zdravilo se uporablja tudi za zdravljenje dedne bolezni, imenovane pomanjkanje BH4 pri odraslih in otrocih vseh starosti, pri kateri telo ne more tvoriti dovolj BH4.
This medicine is diagnostic use only.
To zdravilo je namenjeno samo diagnostični uporabi.
This medicine is essentially ‘potassium-free’ as it contains less than 1 mmol (39 milligrams) of potassium per dose.
Zdravilo vsebuje manj kot 1 mmol (39 miligramov) kalija na odmerek, kar v bistvu pomeni 'brez kalija'.
This medicine is essentially ‘sodium-free’.
Zdravilo je pravzaprav »brez natrija«.
This medicine is for adults aged 18 and over.
To zdravilo je namenjeno odraslim, starim 18 let in več.
This medicine is for oral use.
To zdravilo se zaužije.
This medicine is for single use.
Zdravilo je za enkratno uporabo.
This medicine is given by an injection under the skin (by subcutaneous injection) in either (1) your upper legs (thighs), (2) your abdomen (stomach), and (3) your upper arm (if not self-injecting). (See INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF RELISTOR at the end of this leaflet.)
To zdravilo se daje kot podkožna injekcija (s subkutano injekcijo) v (1) stegno ali (2) trebuh ali (3) nadlaket (če si zdravila ne injicirate sami). (Glejte NAVODILA ZA PRIPRAVO IN DAJANJE INJEKCIJE ZDRAVILA RELISTOR na koncu tega navodila za uporabo zdravila).
This medicine is given by injection, either through an intravenous (IV) infusion (drip) or a subcutaneous (SC) injection (into the tissue just under the skin).
To zdravilo se daje z injekcijo, bodisi z intravensko (i.v.) infuzijo (kapalna) ali s subkutanim (s.c.) injiciranjem (v tkivo tik pod kožo).
This medicine is given by injection, either through an intravenous (IV) infusion (drip) or by a subcutaneous (SC) injection into the tissue just under the skin.
To zdravilo se daje z injekcijo bodisi v obliki intravenske (i.v.) infuzije (kapalne infuzije) ali v tkivo tik pod kožo (s.c.) v obliki subkutane injekcije.
This medicine is given once only at the day of surgery, 2 – 4 hours before start of anaesthesia.
To zdravilo se uporablja samo enkrat, na dan kirurškega posega, 2 do 4 ure pred začetkom anestezije.
This medicine is given using the Ovaleap Pen.
Zdravilo se daje z uporabo injekcijskega peresnika Ovaleap Pen.
This medicine is intended for adults only.
Zdravilo je namenjeno samo odraslim.
This medicine is intended for intravenous administration only and should be administered within 3 hours after reconstitution.
To zdravilo je namenjeno samo za intravensko uporabo in ga je treba uporabiti v 3 urah po rekonstituciji.
This medicine is intended to treat one area of 25 cm2 for three days.
To zdravilo je namenjeno zdravljenju enega mesta v velikosti 25 cm2 za tri dni.
This medicine is intended to treat one area of 25 cm2 for two days.
To zdravilo je namenjeno zdravljenju enega mesta v velikosti 25 cm2 za dva dni.
This medicine is normally given by a doctor or nurse.
To zdravilo lahko daje zdravnik ali medicinska sestra.
This medicine is not a cure for HIV infection.
To zdravilo ne pozdravi okuţbe z virusom HIV.
This medicine is not expected to affect your ability to drive or use machines.
Ni pričakovati, da bi to zdravilo vplivalo na sposobnost vožnje in upravljanja strojev.
This medicine is not expected to have any effect on the ability to drive or use machines.
Ne pričakuje se, da bi to zdravilo vplivalo na sposobnost vožnje ali upravljanja s stroji.
This medicine is not expected to have any effect on your ability to drive or use machines.
Ni pričakovati, da bi to zdravilo vplivalo na sposobnost upravljanja vozil in strojev.
This medicine is not for people who are under 18 years old.
To zdravilo se ne sme uporabljati pri osebah, mlajših od 18 let.
This medicine is not for use in children and adolescents below 18 years old.
To zdravilo ni namenjeno otrokom in mladostnikom, mlajšim od 18 let.
This medicine is not for use in children and adolescents.
Zdravilo ni namenjeno za uporabo pri otrocih in mladostnikih.
This medicine is not for use in children or adolescents below 18 years of age.
Tega zdravila ne smejo uporabljati otroci in mladostniki, stari manj kot 18 let.
This medicine is not indicated for use in children and adolescents less than 18 years of age.
To zdravilo ni indicirano za uporabo pri otrocih in mladostnikih, starih manj kot 18 let.
This medicine is not intended for use in children or adolescents below the age of 18 years.
To zdravilo ni namenjeno za uporabo pri otrocih ali mladostnikih, mlajših od 18 let.
This medicine is not likely to affect your being able to drive and use any tools or machines.
Ni verjetno, da bo zdravilo vplivalo na vašo sposobnost vožnje in uporabe orodij in strojev.
This medicine is not recommended for children under 12 years due to the lack of data in these patients.
To zdravilo zaradi pomanjkanja podatkov za otroke, mlajše od 12 let, ni priporočljivo pri teh bolnikih.
This medicine is not recommended for infants less than 2 years of age.
Uporaba tega zdravila ni priporočljiva za dojenčke, mlajše od 2 let.